Non-Communicable Chronic DiseasesNCT06581770
Evaluation of Validity and Reliability of the Turkish Translation of the Digital Health Readiness Questionaire in Different Chronic Diseases
An observational study of Non-Communicable Chronic Diseases and Survey and Questionnaire, run by Istanbul Galata University at 1 site in Turkey (Türkiye).
Trial summary
The World Health Organization (WHO) defines digital health as the field of knowledge and application related to any aspect of the adoption of digital technology in the stages of improvement. The combination of digital health with technology brings about a new transformation in digital media. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Non-Communicable Chronic Diseases, Survey and Questionnaire, Validation Studies
- What is being tested?
- Survey using a questionnaire.
- How many people
- 200 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Oct 2024to 15 Sep 2025
- How long will I take part?
- 2 Months
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: This study aimed to include 200 participants who applied as patients to Istanbul Faculty of Medicine, Department of Internal Medical Sciences, Department of Internal Medicine, Diabetes and Obesity Polyclinic and Istanbul Florence Nightingale Hospital, Department of Cardiovascular Surgery between September 2024 and August 2025 and met the inclusion criteria, based on the ethics committee approvals obtained from Biruni University Clinical Research Ethics Committee, decision number 2015-KAEK-68-22-01 dated 28.07.2022, and the ethics committee approvals obtained from Biruni University Non-Interventional Clinical Research Ethics Committee, decision number 2023/85-65 dated 22.12.2023.
Who may be able to join
- The study will include people over the age of 18, native Turkish speakers, literate, obese, diabetic, cardiovascular and respiratory patients.
Who cannot join
- Individuals with insufficient cooperation (Mini Mental Test score \<24) and any cognitive problems that may prevent the administration of the survey will be excluded from the study.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Buket Akinci contact
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
Biruni University
Istanbul, Istanbul
Busra Ulker Eksi, +905382604569, bbusraulker@gmail.com
About this study
The World Health Organization (WHO) defines digital health as the field of knowledge and application related to any aspect of the adoption of digital technology in the stages of improvement. The combination of digital health with technology brings about a new transformation in digital media. This transformation allows for the development of communication and information in health services, the ability to conduct health-related research on digital media and the evaluation of this data. The ease of access to information and the provision of a timely feedback mechanism in the face of problems have enabled the spread of digital health systems, and have also enabled chronic disease management and epidemic disease monitoring.
It is recommended that the term digital readiness be used to cover the combination of digital access and use, digital literacy and digital health literacy. Digital health readiness is also defined as the main determinant of health and is thought to contribute to the improvement of health processes with the development of digital health literacy and to be a useful solution against health problems that may arise in the follow-up of chronic diseases.
Although there are tools in the literature that evaluate digital health readiness, there is no Turkish assessment tool that facilitates the follow-up of non-communicable chronic diseases. Therefore, the aim of our study is to evaluate the translation, validity, and reliability of the Digital Health Readiness Questionaire into Turkish in individuals with chronic non-infectious diseases.
- Conditions
- Non-Communicable Chronic Diseases, Survey and Questionnaire, Validation Studies, Digital Health
- Being tested
- Survey using a questionnaire.
- Keywords
- digital health, Digital Health Readiness Questionaire
- Medical subject headings
- Noncommunicable Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Survey using a questionnaire.Other
It is a validity and reliability study that can evaluate digital health readiness.
Survey using a questionnaire.Other
This is a reliability and validity study.
What is being measured
The primary outcome is the main question the study is designed to answer.
Translation of the digital health readiness questionnaire
Translation of the digital health readiness questionnaire into Turkish and application on the sample
Measured: 1 month
Secondary outcomes (1)
the validity and reliability of the survey in Turkish
To evaluate the translation, validity and reliability of the Digital Health Readiness Survey into Turkish in individuals with chronic non-communicable diseases.
Measured: 11 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Sep 2024
- Study start15 Oct 2024
- Primary completion15 Apr 2025 (estimated)
- Study completion15 Sep 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Non-Communicable Chronic DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 200 participants (estimated)
- Target duration
- 2 Months
Sponsor and investigators
- Lead sponsor
- Istanbul Galata University
- Sponsor type
- University, hospital or other
- Collaborators
- Biruni University, Istanbul University - Cerrahpasa
- Responsible party
- Principal investigator, Busra Ulker Eksi, Istanbul Galata University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06581770
- Sponsor's protocol ID
- AA1234
- Status last verified
- Feb 2025
- First submitted
- 30 Aug 2024
- Last updated
- 10 Feb 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 10 Feb 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Validity and Reliability of the Turkish Translation of the Digital Health Readiness Questionaire in Different Chronic Diseases
- ClinicalTrials.gov ID
- NCT06581770
- Acronym / sponsor ID
- AA1234
- Conditions
- Non-Communicable Chronic Diseases, Survey and Questionnaire, Validation Studies, Digital Health
- Keywords
- digital health, Digital Health Readiness Questionaire
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Istanbul Galata UniversityUniversity, hospital or other
- Collaborators
- Biruni University, Istanbul University - Cerrahpasa
- Study start
- 15 Oct 2024 (actual)
- Primary completion
- 15 Apr 2025 (estimated)
- Study completion
- 15 Sep 2025 (estimated)
- First posted
- 3 Sep 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The World Health Organization (WHO) defines digital health as the field of knowledge and application related to any aspect of the adoption of digital technology in the stages of improvement. The combination of digital health with technology brings about a new transformation in digital media. This transformation allows for the development of communication and information in health services, the ability to conduct health-related research on digital media and the evaluation of this data. The ease of access to information and the provision of a timely feedback mechanism in the face of problems have enabled the spread of digital health systems, and have also enabled chronic disease management and epidemic disease monitoring.
It is recommended that the term digital readiness be used to cover the combination of digital access and use, digital literacy and digital health literacy. Digital health readiness is also defined as the main determinant of health and is thought to contribute to the improvement of health processes with the development of digital health literacy and to be a useful solution against health problems that may arise in the follow-up of chronic diseases.
Although there are tools in the literature that evaluate digital health readiness, there is no Turkish assessment tool that facilitates the follow-up of non-communicable chronic diseases. Therefore, the aim of our study is to evaluate the translation, validity, and reliability of the Digital Health Readiness Questionaire into Turkish in individuals with chronic non-infectious diseases.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Target follow-up
- 2 Months
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- This study aimed to include 200 participants who applied as patients to Istanbul Faculty of Medicine, Department of Internal Medical Sciences, Department of Internal Medicine, Diabetes and Obesity Polyclinic and Istanbul Florence Nightingale Hospital, Department of Cardiovascular Surgery between September 2024 and August 2025 and met the inclusion criteria, based on the ethics committee approvals obtained from Biruni University Clinical Research Ethics Committee, decision number 2015-KAEK-68-22-01 dated 28.07.2022, and the ethics committee approvals obtained from Biruni University Non-Interventional Clinical Research Ethics Committee, decision number 2023/85-65 dated 22.12.2023.
Key inclusion criteria (1 listed)
- The study will include people over the age of 18, native Turkish speakers, literate, obese, diabetic, cardiovascular and respiratory patients.
Key exclusion criteria (1 listed)
- Individuals with insufficient cooperation (Mini Mental Test score \<24) and any cognitive problems that may prevent the administration of the survey will be excluded from the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Survey using a questionnaire.It is a validity and reliability study that can evaluate digital health readiness. | Other | – |
| Survey using a questionnaire.This is a reliability and validity study. | Other | – |
Primary outcome
Translation of the digital health readiness questionnaire
Time frame: 1 month
Translation of the digital health readiness questionnaire into Turkish and application on the sample
1 secondary outcome
the validity and reliability of the survey in Turkish
Time frame: 11 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Feb 2025.
- Individual participant dataSharing planned: Undecided
Related trials for Non-Communicable Chronic Diseases
RecruitingObservational study
"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
Chronic Liver Disease and Cirrhosis, Liver Cancer
RecruitingObservational study
CytOSorb TreatMent Of Critically Ill PatientS Registry
Septic Shock, Acute Respiratory Distress Syndrome
RecruitingObservational study
Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data
Non-communicable Diseases (NCD), Neoplams
RecruitingObservational study
Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease
Chronic Hepatitis B, Nonalcoholic Fatty Liver Disease
Not yet recruitingObservational study
Wearable Patch Ultrasound Probe for Diagnosis of Liver Stiffness
Liver Fibrosis, Liver Cirrhosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Buket Akinci contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Non-Communicable Chronic Diseases and Survey and Questionnaire, run by Istanbul Galata University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 10 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Busra Ulker Eksi (+905382604569, bbusraulker@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Translation of the digital health readiness questionnaire (time frame: 1 month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Feb 2025.